Study to Evaluate the safety and efficacy of Navroop- DS in patients suffering from Oligomenorrhea.
- Conditions
- Health Condition 1: N915- Oligomenorrhea, unspecified
- Registration Number
- CTRI/2023/10/058629
- Lead Sponsor
- Ambic Ayurved India Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Females from 18 to 45 years of age.
2. Females suffering from Oligomenorrhea.
3. If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.
4. Females that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
5. Females willing to avoid participation in any other interventional clinical trial for the duration of the study.
1. Females that are pregnant, breast feeding, or planning to get pregnant during the study.
2. Females that have participated in any other interventional clinical trial in the previous 90 days.
3. Females with known sensitivity to any of the constituents of the investigational product.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method